• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体肿瘤转化基因-1作为胃癌的独立预后生物标志物。

Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.

作者信息

Xu Mi-die, Dong Lei, Qi Peng, Weng Wei-wei, Shen Xiao-han, Ni Shu-juan, Huang Dan, Tan Cong, Sheng Wei-qi, Zhou Xiao-yan, Du Xiang

机构信息

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Gastric Cancer. 2016 Jan;19(1):107-15. doi: 10.1007/s10120-015-0459-2. Epub 2015 Jan 28.

DOI:10.1007/s10120-015-0459-2
PMID:25627474
Abstract

BACKGROUND

Pituitary tumor-transforming gene-1 (PTTG1) is a transcription factor that can affect transcriptional activity, angiogenesis, and cell senescence. We examined PTTG1 mRNA and protein expression in gastric cancer (GC) cell lines and tissues to determine its value as a biomarker for GC diagnosis and therapy.

METHODS

PTTG1 mRNA expression from 78 GC cases and paired adjacent normal mucosa (PCR cohort) as well as from five gastric cell lines was assessed using qRT-PCR. Nuclear and cytoplasmic RNA were extracted from two gastric cell lines to determine PTTG1 mRNA localization. PTTG1 protein expression from 98 GC cases, their paired adjacent normal mucosa, and 23 gastric intraepithelial neoplasia (GIN) cases was examined using immunohistochemistry (IHC cohort). The correlation between PTTG1 mRNA and protein expression and GC clinicopathological parameters was analyzed.

RESULTS

PTTG1 mRNA expression in GC tissues and cell lines was significantly increased compared with adjacent normal gastric mucosa and normal gastric mucous cell lines (p < 0.05). PTTG1 expression was nuclear and cytoplasmic, with higher cytoplasmic expression. PTTG1 immunostaining significantly differed in GC (95.66 ± 20.65), GIN (84.00 ± 34.16), and normal adjacent mucosa (28 ± 22.25) (p < 0.001). Multivariate Cox regression analysis revealed that PTTG1 mRNA and protein expression are independent prognostic factors for GC patient survival.

CONCLUSION

Our results suggest that PTTG1 is a promising target for GC diagnosis and therapy.

摘要

背景

垂体肿瘤转化基因-1(PTTG1)是一种转录因子,可影响转录活性、血管生成和细胞衰老。我们检测了胃癌(GC)细胞系和组织中PTTG1 mRNA和蛋白表达,以确定其作为GC诊断和治疗生物标志物的价值。

方法

使用qRT-PCR评估78例GC病例及其配对的相邻正常黏膜(PCR队列)以及5种胃细胞系中PTTG1 mRNA表达。从两种胃细胞系中提取核RNA和细胞质RNA,以确定PTTG1 mRNA的定位。使用免疫组织化学(IHC队列)检测98例GC病例、其配对的相邻正常黏膜以及23例胃上皮内瘤变(GIN)病例中PTTG1蛋白表达。分析PTTG1 mRNA和蛋白表达与GC临床病理参数之间的相关性。

结果

与相邻正常胃黏膜和正常胃黏液细胞系相比,GC组织和细胞系中PTTG1 mRNA表达显著增加(p < 0.05)。PTTG1表达存在于细胞核和细胞质中,细胞质表达更高。PTTG1免疫染色在GC(95.66 ± 20.65)、GIN(84.00 ± 34.16)和相邻正常黏膜(28 ± 22.25)中存在显著差异(p < 0.001)。多变量Cox回归分析显示,PTTG1 mRNA和蛋白表达是GC患者生存的独立预后因素。

结论

我们的结果表明,PTTG1是GC诊断和治疗的一个有前景的靶点。

相似文献

1
Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.垂体肿瘤转化基因-1作为胃癌的独立预后生物标志物。
Gastric Cancer. 2016 Jan;19(1):107-15. doi: 10.1007/s10120-015-0459-2. Epub 2015 Jan 28.
2
Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis.非小细胞肺癌中垂体瘤转化基因-1:临床病理与免疫组化分析
Biomed Pharmacother. 2016 Dec;84:1595-1600. doi: 10.1016/j.biopha.2016.10.047. Epub 2016 Nov 6.
3
Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.B细胞易位基因1在胃癌组织病理学和解剖学亚型中的表达及其临床意义的多样性
Dig Dis Sci. 2015 May;60(5):1256-64. doi: 10.1007/s10620-014-3477-8. Epub 2014 Dec 9.
4
Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis.髓样锌指蛋白1表达在胃癌发生发展中的临床意义
Cell Physiol Biochem. 2017;44(3):1242-1250. doi: 10.1159/000485454. Epub 2017 Nov 28.
5
The clinical value and biological function of PTTG1 in colorectal cancer.PTTG1 在结直肠癌中的临床价值和生物学功能。
Biomed Pharmacother. 2017 May;89:108-115. doi: 10.1016/j.biopha.2017.01.115. Epub 2017 Feb 20.
6
Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.眼 sine 同源盒 1 蛋白作为胃腺癌的独立生物标志物
Exp Mol Pathol. 2014 Aug;97(1):74-80. doi: 10.1016/j.yexmp.2014.05.007. Epub 2014 May 24.
7
H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.H19 可作为诊断生物标志物,H19 表达上调与胃癌患者预后不良有关。
Neoplasma. 2016;63(2):223-30. doi: 10.4149/207_150821N454.
8
Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.SOX11 启动子甲基化异常与胃癌预后不良相关。
Cell Oncol (Dordr). 2015 Jun;38(3):183-94. doi: 10.1007/s13402-015-0219-7. Epub 2015 Mar 24.
9
SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.SMYD3过表达是胃癌生物学行为和预后的一个危险因素。
Tumour Biol. 2015 Apr;36(4):2685-94. doi: 10.1007/s13277-014-2891-z. Epub 2014 Dec 4.
10
AKR1B10, a good prognostic indicator in gastric cancer.AKR1B10 是胃癌的一个预后良好的指标。
Eur J Surg Oncol. 2014 Mar;40(3):318-24. doi: 10.1016/j.ejso.2013.12.014. Epub 2013 Dec 31.

引用本文的文献

1
Integration of single-cell and bulk RNA sequencing identifies and validates T cell-related prognostic model in hepatocellular carcinoma.单细胞和批量RNA测序的整合鉴定并验证了肝细胞癌中与T细胞相关的预后模型。
PLoS One. 2025 May 2;20(5):e0322706. doi: 10.1371/journal.pone.0322706. eCollection 2025.
2
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways.肿瘤进展中细胞衰老的调控与治疗靶点:机制与途径
Mol Cancer. 2025 Apr 2;24(1):106. doi: 10.1186/s12943-025-02284-z.
3
Bioinformatic Analysis of PTTG Family and Prognosis and Immune Cell Infiltration in Gastric Cancer.

本文引用的文献

1
Pituitary-tumour-transforming-gene 1 expression in testicular cancer.垂体肿瘤转化基因1在睾丸癌中的表达
Andrologia. 2015 May;47(4):427-32. doi: 10.1111/and.12283. Epub 2014 Apr 22.
2
Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.Pttg1/securin 对于乳腺的分支形态发生是必需的,并且抑制乳腺肿瘤发生。
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1008-13. doi: 10.1073/pnas.1318124111. Epub 2014 Jan 6.
3
PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.
胃癌中PTTG家族的生物信息学分析及其与预后和免疫细胞浸润的关系
Stem Cells Int. 2023 Feb 4;2023:6905216. doi: 10.1155/2023/6905216. eCollection 2023.
4
Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice.在小鼠生槟榔诱导的致癌过程中,securin过表达与激活的Rb/E2F1通路及组蛋白H3表观遗传修饰相关。
Cancer Cell Int. 2022 Jan 15;22(1):30. doi: 10.1186/s12935-022-02442-z.
5
Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization.基于多水平整合和全局网络优化的胃癌新型预后标志物的鉴定
Front Cell Dev Biol. 2021 Apr 12;9:631534. doi: 10.3389/fcell.2021.631534. eCollection 2021.
6
[Expression of pituitary tumor-transforming gene-1 and its pathogenic role in systemic sclerosis].[垂体瘤转化基因-1的表达及其在系统性硬化症中的致病作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1564-1570. doi: 10.12122/j.issn.1673-4254.2020.11.05.
7
GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer.GCNT4与胃癌预后相关并抑制胃癌细胞增殖。
Onco Targets Ther. 2020 Aug 25;13:8601-8613. doi: 10.2147/OTT.S248997. eCollection 2020.
8
Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.利用生物信息学分析方法鉴定胃癌中的关键基因以预测预后
Ann Transl Med. 2020 Jul;8(14):884. doi: 10.21037/atm-20-4427.
9
Recent advances in gastric cancer early diagnosis.胃癌早期诊断的最新进展。
World J Gastroenterol. 2019 May 7;25(17):2029-2044. doi: 10.3748/wjg.v25.i17.2029.
10
The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.长链非编码RNA PTTG3P通过PTTG1促进宫颈癌的生长和转移。
Aging (Albany NY). 2019 Mar 10;11(5):1333-1341. doi: 10.18632/aging.101830.
在肾上腺皮质癌中 PTTG1 的过表达与不良预后相关,并且是一个潜在的治疗靶点。
Surgery. 2013 Dec;154(6):1405-16; discussion 1416. doi: 10.1016/j.surg.2013.06.058.
4
Low expression of LOC285194 is associated with poor prognosis in colorectal cancer.LOC285194的低表达与结直肠癌的不良预后相关。
J Transl Med. 2013 May 16;11:122. doi: 10.1186/1479-5876-11-122.
5
Expression and the clinical significance of hPTTG1 in gastric cancer.胃癌中 hPTTG1 的表达及临床意义。
Mol Med Rep. 2013 Jan;7(1):43-6. doi: 10.3892/mmr.2012.1161. Epub 2012 Nov 1.
6
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.PTTG1 癌基因的表达与侵袭性透明细胞肾细胞癌相关。
Cancer Res. 2012 Sep 1;72(17):4361-71. doi: 10.1158/0008-5472.CAN-11-2330. Epub 2012 Jul 17.
7
Transcriptional targets for pituitary tumor-transforming gene-1.垂体瘤转化基因 1 的转录靶标。
J Mol Endocrinol. 2009 Nov;43(5):179-85. doi: 10.1677/JME-08-0176. Epub 2009 May 11.
8
PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.垂体瘤转化基因(PTTG)过表达促进人食管鳞状细胞癌的淋巴结转移。
Cancer Res. 2009 Apr 15;69(8):3283-90. doi: 10.1158/0008-5472.CAN-08-0367. Epub 2009 Apr 7.
9
PTTG: an important target gene for ovarian cancer therapy.PTTG:卵巢癌治疗的重要靶标基因。
J Ovarian Res. 2008 Oct 20;1(1):6. doi: 10.1186/1757-2215-1-6.
10
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.鉴定TACC1、NOV和PTTG1作为与乳腺癌内分泌治疗耐药相关的新候选基因。
J Mol Endocrinol. 2009 Feb;42(2):87-103. doi: 10.1677/JME-08-0076. Epub 2008 Nov 4.